Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313857553> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4313857553 abstract "To investigate long-term effectiveness and safety of subcutaneous tocilizumab (TCZ-SC) in the routine clinical care of patients with rheumatoid arthritis (RA).ARATA (ML29087) was a prospective, multicentre, observational study of adult patients with active RA initiating therapy with TCZ-SC. The primary effectiveness outcome was the proportion of patients achieving DAS28-ESR <2.6 at week 104. Additional efficacy outcomes included individual DAS28-dcrit responses (improvement of ≥1.8 from baseline), CDAI remission (≤2.8), and patient-reported outcomes (PROs), including Work Productivity and Activity Impairment scores. Adverse event rates were used to evaluate safety and tolerability.Between May 2014 and July 2018, 114 study centres in Germany enrolled 1,300 patients with RA who received at least one dose of TCZ-SC (mean age 57.3 [SD 12.5] years, mean DAS28-ESR of 4.9 [SD 1.3]). At week 104, 58.7% (365/622) patients achieved DAS28-ESR <2.6, 64.0% had an individual DAS28-dcrit response, and 31.4% (241/767) achieved CDAI remission. PROs, including patient global assessment, pain, and fatigue, showed marked improvements from baseline. Work outcomes, including absenteeism (missed work) and presenteeism (productivity while at work), also improved. Injection reactions were rare and no new safety signals occurred. Patients expressed a high level of satisfaction with treatment. Baseline patient characteristics and outcomes were similar for ARATA and ICHIBAN (an observational study of TCZ-IV in Germany), despite different formulations and time periods.The safety and effectiveness of TCZ-SC is maintained over 2 years during routine clinical care. TCZ-SC represents a convenient and effective option for RA patients who prefer SC administration." @default.
- W4313857553 created "2023-01-10" @default.
- W4313857553 creator A5003263905 @default.
- W4313857553 creator A5011323027 @default.
- W4313857553 creator A5012842018 @default.
- W4313857553 creator A5052946257 @default.
- W4313857553 creator A5060471170 @default.
- W4313857553 creator A5063937523 @default.
- W4313857553 creator A5064581168 @default.
- W4313857553 creator A5081002197 @default.
- W4313857553 creator A5090130883 @default.
- W4313857553 creator A5091190600 @default.
- W4313857553 date "2022-06-21" @default.
- W4313857553 modified "2023-10-18" @default.
- W4313857553 title "Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational study" @default.
- W4313857553 doi "https://doi.org/10.55563/clinexprheumatol/hlmsao" @default.
- W4313857553 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36622132" @default.
- W4313857553 hasPublicationYear "2022" @default.
- W4313857553 type Work @default.
- W4313857553 citedByCount "0" @default.
- W4313857553 crossrefType "journal-article" @default.
- W4313857553 hasAuthorship W4313857553A5003263905 @default.
- W4313857553 hasAuthorship W4313857553A5011323027 @default.
- W4313857553 hasAuthorship W4313857553A5012842018 @default.
- W4313857553 hasAuthorship W4313857553A5052946257 @default.
- W4313857553 hasAuthorship W4313857553A5060471170 @default.
- W4313857553 hasAuthorship W4313857553A5063937523 @default.
- W4313857553 hasAuthorship W4313857553A5064581168 @default.
- W4313857553 hasAuthorship W4313857553A5081002197 @default.
- W4313857553 hasAuthorship W4313857553A5090130883 @default.
- W4313857553 hasAuthorship W4313857553A5091190600 @default.
- W4313857553 hasBestOaLocation W43138575531 @default.
- W4313857553 hasConcept C126322002 @default.
- W4313857553 hasConcept C141071460 @default.
- W4313857553 hasConcept C162324750 @default.
- W4313857553 hasConcept C1862650 @default.
- W4313857553 hasConcept C187736073 @default.
- W4313857553 hasConcept C197934379 @default.
- W4313857553 hasConcept C23131810 @default.
- W4313857553 hasConcept C27400517 @default.
- W4313857553 hasConcept C2777178219 @default.
- W4313857553 hasConcept C2777575956 @default.
- W4313857553 hasConcept C2778375690 @default.
- W4313857553 hasConcept C71924100 @default.
- W4313857553 hasConceptScore W4313857553C126322002 @default.
- W4313857553 hasConceptScore W4313857553C141071460 @default.
- W4313857553 hasConceptScore W4313857553C162324750 @default.
- W4313857553 hasConceptScore W4313857553C1862650 @default.
- W4313857553 hasConceptScore W4313857553C187736073 @default.
- W4313857553 hasConceptScore W4313857553C197934379 @default.
- W4313857553 hasConceptScore W4313857553C23131810 @default.
- W4313857553 hasConceptScore W4313857553C27400517 @default.
- W4313857553 hasConceptScore W4313857553C2777178219 @default.
- W4313857553 hasConceptScore W4313857553C2777575956 @default.
- W4313857553 hasConceptScore W4313857553C2778375690 @default.
- W4313857553 hasConceptScore W4313857553C71924100 @default.
- W4313857553 hasLocation W43138575531 @default.
- W4313857553 hasLocation W43138575532 @default.
- W4313857553 hasOpenAccess W4313857553 @default.
- W4313857553 hasPrimaryLocation W43138575531 @default.
- W4313857553 hasRelatedWork W1996887190 @default.
- W4313857553 hasRelatedWork W2104386994 @default.
- W4313857553 hasRelatedWork W2156283049 @default.
- W4313857553 hasRelatedWork W2232273633 @default.
- W4313857553 hasRelatedWork W2316954211 @default.
- W4313857553 hasRelatedWork W2970100988 @default.
- W4313857553 hasRelatedWork W2999730687 @default.
- W4313857553 hasRelatedWork W4251265868 @default.
- W4313857553 hasRelatedWork W4294301186 @default.
- W4313857553 hasRelatedWork W2899737214 @default.
- W4313857553 isParatext "false" @default.
- W4313857553 isRetracted "false" @default.
- W4313857553 workType "article" @default.